Zindaclin (clindamycin gel)

Pronunciation: ZIN-da-klin.

Generic name
clindamycin phosphate (topical)
Drug class
Lincosamide antibiotic, topical formulation
Form
Gel, 1% w/w (clindamycin phosphate equivalent to 1% clindamycin)
Route
Topical (applied to the skin)
Legal status
Prescription-only

Availability and supply rules vary by country

Trade names by country: United States · United Kingdom · Canada · Australia · New Zealand

Australia: Zindaclin (3) · Full directory

What clindamycin phosphate (topical) is and how it works

Zindaclin is a prescription-only topical gel containing the antibiotic clindamycin, used on the skin to treat mild to moderate acne. It is applied once daily as a thin layer over the affected area. (1)

Use Zindaclin exactly as your prescriber or pharmacist directs, applying it only to the skin and avoiding your eyes and the inside of your mouth, nose, and other mucous membranes.

Mechanism of action: how clindamycin phosphate (topical) works

Clindamycin is a lincosamide antibiotic that inhibits bacterial protein synthesis by binding the 50S ribosomal subunit, active against Cutibacterium acnes and other organisms implicated in acne. Systemic absorption from topical use is minimal (in vitro penetration under 5%, median plasma levels below 2 ng/mL at clinical doses in the source reviewed), but clinically meaningful absorption sufficient to cause systemic effects, including Clostridioides difficile-associated diarrhoea/colitis, has been documented. (1) (4)

What clindamycin phosphate (topical) is used for

Mild to moderate acne vulgaris

Used on the skin to help treat mild to moderate acne vulgaris in adults and adolescents aged 12 years and over. (1)

Before taking clindamycin phosphate (topical)

Do not take / not appropriate for

  • Do not use Zindaclin if you have had a serious allergic reaction to clindamycin, lincomycin, or any of the ingredients. (all countries) (1) (4)
  • Use with particular caution, and only if your prescriber agrees it is appropriate, if you have a personal history of antibiotic-associated colitis, ulcerative colitis, or regional enteritis (Crohn's disease), since clindamycin -- including topical forms -- has a genuine, if uncommon, association with severe bowel inflammation. (all countries) (1) (4)
  • Not recommended for children under 12 years old. (United Kingdom, European Union) (1)

Tell your clinician about

  • Any personal history of bowel conditions such as colitis or Crohn's disease.
  • Any other topical or oral acne treatments or antibiotics you are using.
  • Whether you are pregnant, could become pregnant, or are breastfeeding.
(1)

How to take clindamycin phosphate (topical)

  • Wash and dry the affected skin gently before applying.
  • Apply a thin film of gel once daily to the affected area only, avoiding the eyes, lips, mouth, nostrils, and other mucous membranes, and broken or irritated skin.
  • Wash your hands after applying, unless your hands are part of the treated area.
  • Avoid other harsh or drying skin products on the same area unless your prescriber or pharmacist advises otherwise, since combined irritation is more likely.
(1)

Procedures and treatment changes

Tell the treating team before surgery, procedures, or any medicine change. Do not alter treatment without the responsible clinician. (1) (2) (3) (4)

Missed dose

If you miss an application, apply it when you remember and continue with your normal daily schedule -- do not apply extra to make up for a missed application. Contact your pharmacist or prescriber if you are unsure.

Overdose

Topical overuse is unlikely to cause serious harm, but seek medical advice if the gel is accidentally swallowed in more than a trivial amount, or if severe skin irritation, watery or bloody diarrhoea, or other concerning symptoms develop. (1) (4)

Side effects

Side effects and their urgency vary; report severe, persistent, or concerning symptoms.

Dry skin.

What to notice: Dry skin.

What to do: Discuss persistent or troublesome symptoms with the treating clinician or pharmacist. (1)

Redness (erythema) and a burning sensation.

What to notice: Redness (erythema) and a burning sensation.

What to do: Discuss persistent or troublesome symptoms with the treating clinician or pharmacist. (1)

Itching (pruritus) and skin peeling.

What to notice: Itching (pruritus) and skin peeling.

What to do: Discuss persistent or troublesome symptoms with the treating clinician or pharmacist. (1) (4)

Serious warnings

Signs of severe bowel inflammation (Clostridioides difficile-associated diarrhoea/colitis) — emergency

Symptoms: Watery or bloody diarrhoea, severe abdominal cramping or pain, or fever, which can develop during treatment or, in some reported cases, several weeks after treatment ends. This is a genuine, documented risk of topical clindamycin, not only oral or injected forms, because some of the medicine can be absorbed into the body through the skin.

Action: Contact your prescriber or seek medical attention promptly if this occurs. Do not use anti-diarrhoeal (antiperistaltic) medicines to manage this yourself, as they may worsen the condition -- your prescriber will decide on the right course of action, including whether to continue treatment. (1) (4)

Signs of a serious allergic reaction — emergency

Symptoms: Swelling of the face, lips, tongue, or throat; difficulty breathing; widespread rash or hives.

Action: Seek emergency medical help immediately. (1)

Interactions

  • Using other topical acne treatments, exfoliants, or antibiotics on the same skin at the same time may increase irritation -- check with your pharmacist or prescriber before combining products. (1)
  • Clindamycin can add to the effect of neuromuscular blocking medicines used during anaesthesia -- tell any anaesthetist or surgical team that you use topical clindamycin before a procedure. (4)

Pregnancy, breastfeeding, kidney/liver function, age

Pregnancy

Data on use during pregnancy are limited; the potential benefits and risks should be weighed with your prescriber before use. (1) (2) (3) (4)

Breastfeeding

Clindamycin can pass into breast milk even when used only on the skin, so breastfeeding is not recommended while using this product without discussing it with your prescriber. (1) (2) (3) (4)

Children

Not recommended for children under 12 years old, per the UK/EU labelling reviewed. (1) (2) (3) (4)

Elderly

No specific dose adjustment based on age alone is described in the sources reviewed. (1) (2) (3) (4)

Hepatic_impairment

Not specifically addressed with a dose adjustment in the sources reviewed for this topical product. (1) (2) (3) (4)

Renal_impairment

Not specifically addressed with a dose adjustment in the sources reviewed for this topical product. (1) (2) (3) (4)

Source_ids

UK-EMC-ZINDACLIN-2026,US-CLINDAGEL-DAILYMED-EQUIVALENT-2026 (1) (2) (3) (4)

Monitoring

Before starting

  • Review of any personal history of bowel conditions (colitis, Crohn's disease)
  • Review of other topical or oral acne treatments in use

During treatment

  • Watching for new or worsening diarrhoea, especially if watery or bloody.
  • Watching for excessive skin dryness, irritation, or peeling that does not settle.
(1)

Storage

Store at room temperature, away from direct heat and light, and out of reach of children, following the specific storage instructions and expiry date on the pack.

Professional information

Clinician-facing context only, sourced from the current UK SmPC and the equivalent US FDA-approved clindamycin phosphate gel label; verify against the current full label for the specific product dispensed before prescribing.

United Kingdom / European Union

Indication: Mild to moderate acne vulgaris, adults and adolescents 12 years and over

Dose summary: Apply a thin film once daily to the affected area. Not recommended under 12 years. Caution advised in patients with a history of antibiotic-associated colitis or inflammatory bowel disease.

Renal context: Not separately detailed in the source reviewed for this topical product. (1)

Mechanism of action

Hepatic guidance

Not specifically addressed with a dose adjustment in the sources reviewed for this topical product.

Overdose note

Topical overuse is unlikely to cause significant systemic toxicity; manage symptomatically and monitor for gastrointestinal symptoms if ingestion is suspected. (1) (4)

Frequently asked questions

Is Zindaclin available in the US, UK, Europe, Canada, Australia, and New Zealand?

Zindaclin is confirmed as an authorised brand in the United Kingdom and multiple European Union countries. It was previously registered in Australia, but that registration was cancelled at the sponsor's own request in 2024. Its authorisation status under this specific brand name could not be confirmed in the United States, Canada, or New Zealand -- those markets have other branded clindamycin phosphate gel products with the same active ingredient. (1) (2) (3)

Can a topical acne gel really cause diarrhoea or colitis?

Yes -- although rare, topical clindamycin can be absorbed into the body through the skin in amounts sufficient to cause Clostridioides difficile-associated diarrhoea and colitis, the same serious bowel condition linked to oral and injectable clindamycin. This is a genuine, documented risk, not just a theoretical one, confirmed in both UK and US regulator sources reviewed for this content. (1) (4)

What should I do if I get skin irritation from this gel?

Mild dryness, redness, burning, or peeling are common and often improve with a fragrance-free moisturiser. If irritation is severe, persistent, or accompanied by wider allergic symptoms, contact your prescriber or pharmacist. (1)

What is the mechanism of action of clindamycin phosphate (topical)?

Clindamycin is a lincosamide antibiotic that inhibits bacterial protein synthesis by binding the 50S ribosomal subunit, active against Cutibacterium acnes and other organisms implicated in acne. Systemic absorption from topical use is minimal (in vitro penetration under 5%, median plasma levels below 2 ng/mL at clinical doses in the source reviewed), but clinically meaningful absorption sufficient to cause systemic effects, including Clostridioides difficile-associated diarrhoea/colitis, has been documented. (1) (4)

What is the generic name of Zindaclin (clindamycin gel)?

The generic name is clindamycin phosphate (topical). (1)

What class of drug is clindamycin phosphate (topical)?

Zindaclin (clindamycin gel) is classed as: Lincosamide antibiotic, topical formulation. (1)

References

  1. Zindaclin 1% Gel -- Summary of Product Characteristicselectronic medicines compendium (emc), United Kingdom -- Crawford Healthcare Ltd · United Kingdom · accessed 2026-07-29 · source 1
  2. Clindamycin: list of nationally authorised medicinal products (PSUSA/00000795)European Medicines Agency (EMA) -- PSUSA list of nationally authorised clindamycin-containing medicinal products · European Union · accessed 2026-07-29 · source 2
  3. ZINDACLIN clindamycin (as clindamycin phosphate) 1% topical gel tube -- ARTG registration (cancelled)Therapeutic Goods Administration (TGA), Australia · Australia · accessed 2026-07-29 · source 3
  4. CLINDAGEL (clindamycin phosphate) topical gel, 1% -- full prescribing informationU.S. Food and Drug Administration / DailyMed (NIH), full prescribing information -- for CLINDAGEL (clindamycin phosphate topical gel, 1%), a US-marketed product with the SAME active ingredient, strength, and dosage form as Zindaclin, used here only for shared active-ingredient safety facts since Zindaclin itself is not a confirmed US brand · United States (equivalent active-ingredient product; brand-name availability not confirmed for Zindaclin specifically) · accessed 2026-07-29 · source 4

Brand names by country

Single-ingredient clindamycin phosphate (topical) names are shown separately by country. Product availability, strengths, and supply rules can change; combination products are not included here.

Priority countries

United States

  • Cleocin Phosphate150 mg/mL · pharmacia & upjohn company llc
  • Clindamycin in 5 percent Dextrose18 mg/mL, 6 mg/mL, 12 mg/mL · hikma pharmaceuticals usa inc.
  • Clindamycin Phoaphate Topical USP, 1%10 mg/mL · a-s medication solutions
  • Cleocin75 mg/5mL, 20 mg/g, 100 mg · pharmacia & upjohn company llc
  • Cleocin Hydrochloride75 mg, 300 mg, 150 mg · pharmacia & upjohn company llc
  • Clindacin10 mg/g · medimetriks pharmaceuticals, inc.
  • Clindesse100 mg/5g · padagis israel pharmaceuticals ltd
  • Clindagel10 mg/mL · bausch health us, llc
  • XACIATO100 mg/5g · organon llc
  • Clindacin ETZ10 mg · eurofarma, inc.

United Kingdom

  • Zindaclin (1)MHRA licensed emc smpc confirmed · 1% w/w · Crawford Healthcare Ltd

Canada

  • DALACIN C
  • CLINDAMYCINE-150
  • CLINDAMYCIN IV INFUSION
  • DALACIN T
  • DALACIN C FLAVOURED
  • DALACIN
  • DALACIN C PHOSPHATE
  • CLINDETS
  • CLINDA-T
  • CLINDAMYCIN INJECTION SDZ

Australia

  • Zindaclin (3)TGA ARTG registration cancelled 2024 at sponsor request · 1% w/w · Medis Pharma Pty Ltd (at time of cancellation)

New Zealand

  • Zindaclinbrand not identified in NZ market this session · not applicable
View brands in additional countries.

European Union

Zindaclin (2)

This page provides general reference information about Zindaclin (clindamycin gel) and is not a substitute for advice from the prescriber or pharmacist managing your treatment. All treatment decisions should be made with your prescriber or pharmacist.

Related medicines

Pharmacology